These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 27886796)

  • 1. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
    Sfriso P; Bindoli S; Galozzi P
    Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Efthimiou P; Kontzias A; Ward CM; Ogden NS
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
    Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
    Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment options and safety considerations when treating adult-onset Still's disease.
    Cavalli G; Farina N; Campochiaro C; Baldissera E; Dagna L
    Expert Opin Drug Saf; 2020 Dec; 19(12):1549-1558. PubMed ID: 33078630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.
    Kontzias A; Efthimiou P
    Drugs; 2008; 68(3):319-37. PubMed ID: 18257609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
    Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
    Kadavath S; Efthimiou P
    Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
    Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
    J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of abatacept in a refractory case of adult-onset Still's disease.
    Quartuccio L; Maset M; De Vita S
    Clin Exp Rheumatol; 2010; 28(2):265-7. PubMed ID: 20483052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
    Bindoli S; Baggio C; Doria A; Sfriso P
    Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
    Macovei LA; Burlui A; Bratoiu I; Rezus C; Cardoneanu A; Richter P; Szalontay A; Rezus E
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological treatment in adult-onset Still's disease.
    Pouchot J; Arlet JB
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):477-87. PubMed ID: 23040362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.